Quantcast

Latest diabetic neuropathy Stories

2011-04-26 15:02:00

RICHMOND, Calif., April 26, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported first quarter 2011 financial results and accomplishments.

2011-04-13 21:52:53

Drugs already in development to treat Alzheimer's disease may eventually be tapped for a different purpose altogether: re-growing the ends of injured nerves to relieve pain and paralysis.

2011-04-12 08:07:52

The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain -- the burning or tingling pain in the hands and feet that affects millions of people with diabetes.

2011-02-08 00:11:45

Gilad&Gilad LLC of Reseda (Los Angeles), California, has re-launched Neurofencine(TM), a first-of-its-kind nutraceutical supplement clinically proven for nerve resilience and pain-free nerve functions.

2011-02-02 15:00:00

RICHMOND, Calif., Feb. 2, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported fourth quarter and full year 2010 financial results and accomplishments.

2011-01-27 14:41:20

Researchers have proved that a single "master switch" enzyme, known as aldose reductase, is key in producing excess mucous that clogs the airways of people with asthma and chronic obstructive pulmonary disease (COPD).

2011-01-10 06:00:00

RICHMOND, Calif., Jan. 10, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN).

2010-11-17 15:00:00

RICHMOND, Calif., Nov. 17, 2010 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

2010-11-03 00:00:35

Celebrating Ground-Breaking Alpha Lipoic Acid Discovery Alpha lipoic acid is a remarkable natural substance, with surprisingly diverse and beneficial properties, but diminished by the poor solubility of raw material crystalline alpha lipoic acid powder used in most oral formulations.